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Efficient increase of ɣ-aminobutyric 
acid (GABA) content in tomato 
fruits by targeted mutagenesis
Satoko Nonaka1,2, Chikako Arai3, Mariko Takayama1, Chiaki Matsukura1,2 & Hiroshi Ezura1,2
γ-Aminobutyric acid (GABA) is a non-proteinogenic amino acid that has hypotensive effects. Tomato 
(Solanum lycopersicum L.) is among the most widely cultivated and consumed vegetables in the world 
and contains higher levels of GABA than other major crops. Increasing these levels can further enhance 
the blood pressure-lowering function of tomato fruit. Glutamate decarboxylase (GAD) is a key enzyme 
in GABA biosynthesis; it has a C-terminal autoinhibitory domain that regulates enzymatic function, 
and deleting this domain increases GAD activity. The tomato genome has five GAD genes (SlGAD1–5), 
of which two (SlGAD2 and SlGAD3) are expressed during tomato fruit development. To increase GABA 
content in tomato, we deleted the autoinhibitory domain of SlGAD2 and SlGAD3 using clustered 
regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein (Cas)9 technology. 
Introducing a stop codon immediately before the autoinhibitory domain increased GABA accumulation 
by 7 to 15 fold while having variable effects on plant and fruit size and yield. This is the first study 
describing the application of the CRISPR/Cas9 system to increase GABA content in tomato fruits. Our 
findings provide a basis for the improvement of other types of crop by CRISPR/Cas9-based genetic 
modification.
Lifestyle is closely related to human health. Diet, physical activity, stress, smoking, and drinking are the major 
causes of diseases such as high blood pressure, diabetes, hyperlipidaemia, and obesity. High blood pressure is a 
risk factor for heart diseases and stroke, both of which are leading causes of death worldwide. In addition, as the 
estimated number of patients with high blood pressure reached 1.13 billion in 20151, its prevention and control 
are globally required.
The ɣ-aminobutyric acid (GABA) is a non-proteinogenic amino acid, which is widely found in bacteria, ani-
mals, and plants. Several studies in humans and experimental animals have shown that administration of exoge-
nous GABA is effective in lowering blood pressure of hypertensive patients but not of normotensive one2–4. Since 
dietary therapy is used more preferentially than medication as an initial treatment for patients with mild high 
blood pressure or high-normal blood pressure, intake of GABA through daily diet may help reduce their symp-
toms. To this end, many have attempted to increase GABA content in a variety of local foods, such as tea, rice 
and fermented foods, (i.e. fermented milk, tempeh, yogurt and soy sauce)5–9. As these GABA-enriched products 
brought anti-hypotensive effects in experimental animals or human7, 9–11, daily intake of GABA-enriched foods 
would be an effective way to prevent hypertension.
To further promote the consumption of GABA-enriched foods in daily life, the selection of materials for 
enrichment of GABA may be important, because food culture generally differs among countries. It is considered 
that the ideal material is such a thing consumed worldwide and has high potential to produce GABA. Tomato is 
one of the most produced vegetables in the world and widely consumed in daily diet. In addition, tomato contains 
relatively higher levels of GABA than other major crops12, probably due to its higher productivity and/or capac-
ity to store GABA. In cultivated tomato, GABA is intensively accumulated in green-stage fruits (comprising up 
to 50% of the total free amino acids), but when fruits reach the red stage, GABA levels decline to less than 20% 
of the total free amino acids13, 14. To understand the molecular mechanisms underlying the changes in GABA 
accumulation in tomato fruits, we previously isolated GABA metabolism-related genes from tomato cultivar 
‘Micro-Tom’15. In higher plants, GABA is predominantly metabolized through a pathway called the ‘GABA shunt’, 
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which partially bypasses the tricarboxylic acid (TCA) cycle16. In this pathway, GABA is biosynthesized from glu-
tamate by glutamate decarboxylase (GAD), and then catabolized to succinate by GABA transaminase (GABA-T) 
and succinic semialdehyde dehydrogenase (SSADH) in sequential reactions. We found that at least three GAD 
genes (SlGAD1–3), three GABA-T genes (SlGABA-T1–3), and one SSADH gene (SlSSADH) are expressed during 
tomato fruit development17. Loss of function analyses revealed that the expression of SlGAD2 and/or SlGAD3, 
and SlGABA-T1 is important for GABA biosynthesis and catabolism, respectively14, 18. Thus, GABA levels in 
tomato can be increased by genetically manipulating SlGAD2, SlGAD3 or SlGABA-T1 expression. For example, 
when SlGAD3 was overexpressed using the tomato fruit ripening-specific E8 promoter/Arabidopsis heat shock 
protein (HSP) 18.2 terminator expression cassette, the GABA level of red-stage fruits increased to up to six- or 
seven-fold that of wild-type (WT) tomato19. On the other hand, when SlGABA-T1 expression was suppressed by 
RNA interference under the control of the cauliflower mosaic virus (CaMV) 35S promoter/nopaline synthase ter-
minator expression cassette, the GABA level in red-stage fruits increased to up to 9.2-folds that of WT tomato14. 
It is noteworthy that the fruit specific overexpression of a mutant SlGAD3, in which 87 C-terminal nucleotides 
(corresponding to 29 amino acids) were deleted, was even more effective in increasing the GABA level (11- to 
18-folds that of WT red-stage tomato)19. This was likely the consequence of an increased GAD activity because 
plant GADs generally have an autoinhibitory domain at the C-terminus. This domain is composed of 30–50 
amino acids and, in many cases, it also functions as the calmodulin (CaM)-binding domain (CaMBD). It is con-
sidered that this domain inhibits GAD activity at the physiological pH by folding its active site, and this autoin-
hibition is suppressed when the active site is unfolded by conformational changes via an acidic pH or by binding 
of Ca2+/CaM to the CaMBD at the physiological pH20. Thus, it is assumed that removal of this domain allows the 
enzyme to exert constitutive activity, resulting in high GABA accumulation. As enhanced GABA productivity by 
C-terminal truncation of GAD has been reported in several plant species21–23, this trait would be widely applicable 
for improving GABA accumulation in plant cells.
Concerning the development of breeding materials, the application of mutagenesis has been more accept-
able than that of transgenesis. Thus, we previously attempted to isolate SlGAD3 mutants from a ‘Micro-Tom’ 
ethyl methanesulfonate (EMS) mutant population15. Although approximately 4,500 lines of EMS mutant alleles 
were screened by Targeting Induced Local Lesions In Genomes (TILLING), an efficient tool for screening point 
mutations24, no mutation was found around any C-terminal region of SlGAD3 (Ezura et al., unpublished results).
The Clustered, Regularly Interspaced, Short Palindromic Repeats/CRISPR-associated protein 9 (CRISPR/
Cas9) system is a powerful tool for targeted mutagenesis in various organisms25–28. This system allows induc-
ing double-strand breaks (DSBs) at a specific genome region and mutations, preferentially via the error-prone 
non-homologous end-joining (NHEJ) pathway. Although it requires designing a 20 bp-target sequence at the 
genome region before the protospacer-adjacent motif (PAM) sequence (5′-NGG for the type II CRISPR/Cas9 
system)29, the advantages with respect to ease of construction and high mutagenesis efficiency have accelerated 
the use of this system in various areas of research. In tomato, the CRISPR/Cas9 system has also been applied to 
successfully induce mutations at target sites30–32.
In the present study, we induced mutations at the C-terminal region of two tomato GAD genes (SlGAD2 and 
SlGAD3) utilizing the CRISPR/Cas9 system to produce GABA-enhanced tomato fruits. Insertions and deletions 
were frequently detected at the target sites of the SlGAD2- and SlGAD3-targeted lines. In addition, the GABA 
content was greatly increased in the leaves and red-stage fruits of some mutant lines carrying the mutant allele 
that produced the GAD protein without the C-terminal domain.
Results
CRISPR/Cas9 target sites in SlGAD2 and SlGAD3. To breed a tomato line with high GABA content, the 
C-terminal regions of SlGAD2 and SlGAD3 were targeted by CRISPR/Cas9 technology. To select target sequence, we 
compared 10 amino acid sequences from five plant species (Fig. 1a). The 30 and 48 amino acids at the C terminus as 
target sites were selected for SlGAD2. In SlGAD3, the 37 amino acid was used as a target for CRISPR/Cas9. We used an 
Escherichia coli protein expression system to evaluate the activity of these three SlGADs (referred to as SlGAD2ΔC30, 
SlGAD2ΔC48, and SlGAD3ΔC37) at pH 5.8 (the optimal value for GAD activity) and pH 7.0 (the pH in plant cells) 
(Fig. 1b). C-terminal truncation increased SlGAD activity at pH 5.8 and 7.0 in the absence of Ca2+/CaM, which is an 
enhancer of GAD activity (Fig. 1b). SlGAD2ΔC30, SlGAD2ΔC48, and SlGAD3ΔC37 activity was 2.2, 2.7, and 14.6 
times higher, respectively, at pH 5.8 and 10.2, 16.5, and 12.9 times higher, respectively, at pH 7.0 than that of full-length 
SlGADs. Based on these results, we predicted that inducing the stop codon at 30 and 48 amino acids for SlGAD2 and 
37 amino acids for SlGAD3 via CRISPR/Cas9 would lead to increased GABA accumulation in tomato fruits.
Selection of the T0 lines with mutated target sites. According to above result, we constructed 
CRISPR/Cas9 vectors (TG2C30, TG2C48, and TG3C37). These vectors were introduced into tomato via 
Agrobacterium-mediated transformation33. Fourteen, 16, and 35 tomato lines with single or double copies of 
transgenes were found for TG2C30, TG2C48, and TG3C37, respectively (Supplementary Fig. 1). To detect the 
mutation, the target site on each transgenic line was cloned into a pGEM-T vector (Promega, Madison, WI, USA) 
and the resulting 257 sequence clones were checked by Sanger sequencing. Data was summarized in Table 1. 
Transgenic TG2C30, TG2C48, and TG3C37 lines contained 11, 10, and 9 mutation lines, respectively and each 
target site contained 6, 14, and 10 types of mutation, respectively. Only one of the 31 lines sequenced (TG2C48 
#4) lacked mutations (3.33%; 1/31); the remaining lines presented mutations 3- or 4-bp upstream of PAM. Most 
(59.9%, 154/257) of the sequenced clones presented deletions ranging from a single to more than 200 nucleotides 
and 18.3% (47/257) insertions of a single nucleotide; simultaneous insertions and deletions reached 1.2% (3/257), 
and WT genotypes reached 20.6% (53/257). The most inserted nucleotide was T (55.3%), followed by A (29.8%), 
G (12.8%), and C (2.1%). The zygosity of the 31 T0 plants was predicted from clone sequences (Table 1), and the 
alleles of the target site were classified into four groups: if only one type of mutation was detected, lines were 
www.nature.com/scientificreports/
3SCiEntifiC RepoRts | 7:  7057 | DOI:10.1038/s41598-017-06400-y
presumed to be homozygous (16.1%, 5/31); if there were two types of mutation, they were considered as bi-allelic 
(41.9%, 13/31); if a line had one type of mutation and a WT allele, it was classified as heterozygous (6.5%, 2/31); 
and if more than three types of mutation and the WT were present, we considered that the line was chimeric 
(32.3%, 10/31). If no mutation was detected, then the line was presumed to be WT (3.2%, 1/31).
Characterization of the mutations induced at the C-Terminal region of T0. To verify the introduc-
tion of a stop codon immediately upstream of autoinhibitory domain, its nucleic acid sequence was translated 
to the corresponding amino acid sequence. Mutant lines were thus classified into four types, depending on their 
C-terminal amino acid sequence (Table 2, Supplementary Fig. 2): Type 1 had a stop codon immediately upstream 
of the autoinhibitory domain (i.e., they lacked a C-terminal); Type 2 had a conserved or defective autoinhibitory 
C-terminal domain, and the size of the C-terminal was almost identical to that of WT; Type 3 contained both 
Type 1 and Type 2 C-terminals; and Type 4 contained terminals that were both remarkably short and identical to 
WT C-terminals (Supplementary Fig. 2). Type 3 mutants were the most frequent (15/31 lines), followed by Type 
2 (9/31 lines), Type 1 (4/31 lines), and Type 4 (2/31 lines), which were the rarest. Type frequency varied according 
to target site: Type 2 was most frequent in TG2C30 (7/11 lines), Type 3 in TG2C48 (8/11 lines), and Type 1 in 
TG3C37 (4/9 lines).
Figure 1. Determination of the target sites within SlGADs’ C-terminal regions. (a) Multiple sequence 
alignment of the C-terminal region of 10 plant GADs. The C-terminal of MdGAD1-3, AtGAD1, PhGAD, 
OsGAD1-2, SlGAD1-3 from Malus domestica (apple), Arabidopsis thaliana, Oryza sativa (rice), and Solanum 
lycopersicum (tomato), respectively, which were obtained in a previous study, were compared. The conserved 
tryptophan (W) residue and lysine (K) clusters involved in CaM-binding19, 48 are indicated by an asterisk 
and a black line, respectively. The two glutamate (E) residues functioned as pseudo-substrates and are likely 
involved in autoinhibition in PhGAD43 are indicated as black circle. Accession Numbers: MdGAD1, KC812242; 
MdGAD2, KC812243; MdGAD3, KC812244; AtGAD1, AY094464.1; AtGAD2, U49937.1; PhGAD, L16977; 
SlGAD1, AB359913; SlGAD2, AV359914.1; SlGAD3, AB359915.1; OsGAD1, AB056060; OsGAD2; AB056061. 
(b and c) GAD activity of SlGAD2ΔC30 and SlGAD2ΔC48, and SlGAD3Δ37, respectively, in in vitro assays. 
Crude extracts from Escherichia coli were used in GAD enzymatic assays and Ca2+ was not included in reaction 
buffers. SlGAD2 and SlGAD3 are full-length GADs, whereas SlGAD2ΔC30, SlGAD2ΔC48, and SlGAD3ΔC37 
are truncated GADs at C-terminal positions 30, 48, and 37, respectively. Bars represent the standard deviation 
(n = 3) and asterisks indicate statistical differences in according to the Tukey-Kramer’s test between full-length 
GADs (*P < 0.05 and **P < 0.01).
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Evaluation of GABA accumulation in red stage fruit of T0 mutant lines. We examined the effect of 
the SlGAD mutations on GABA accumulation in red-stage tomato fruits (10 days after the Breaker stage). The 
GABA accumulation was measured by the GABase assay method, which is a simple test to detect GABA (Fig. 2). 
In TG2C30, three of the eight mutant lines (#17, #9, #13) showed 2 to 10 times more GABA than the WT, and 
the highest-accumulation line presented 232.9 ± 7.4 mg/100 g fresh weight (FW) (n = 3, Fig. 2a). Five lines of 
TG2C48 (#56, #57, #13, #17, #12) showed 1.5 to 3.6 more GABA that the WT, with the highest value correspond-
ing to 108.5 ± 26.57 mg/100 g FW (Fig. 2b). Seven lines of TG3C37 (#21, #3, #4, #6, #15, #10, #8) had higher 
GABA accumulation than the WT, reaching 203.3 ± 31.7 mg/100 g FW (Fig. 2c). The other lines in TG2C30 (#24, 
#10, #14, #27, #4), TG2C48 (#10, #4, #7), and TG3C37 (#23, #9) showed similar GABA levels to WT.
Line
T0 T1
Zygosity Genotype Mutation segregation T-DNA
TG2C30
 #17 Bi-allele 5d50, 2d3 2d50, 2d3 2+: 2−
 #9 Chimera 4WT, 2d3, 1i1(A) 13WT 9+: 4−
 #13 Chimera 4WT, 2d1, 1d3 17WT 13+: 4−
 #24 Homozygote 10d3 13d3 10+: 3−
 #14 Homozygote 8d1 16d1 16+
 #27 Homozygote 12d4 12 h 11+: 1−
 #10 Bi-allele 6d3, 2d1 NT NT
 #4 Homozygote 9d4 NT NT
 #5 Homozygote 9d4 NT NT
 #7 Bi-allele 4d3, 3d2 NT NT
 #18 Bi-allele 3d3, 3i1(A) NT NT
Total homozygote plant 
(-CRISPR/Cas9) 33 (5)
TG2C48
 #56 Chimera 4WT, 2d1, 1d5, 1i1(G) 4i1(G), 1d27, 13 h, 6WT 19+: 11−
 #57 Chimera 3d43, 2d2, 1d7, 1i1(A) 13d43, 2i1(G), 1i1(C), 15 h 27+: 11−
 #13 Hetero 11WT, 1i1(G) 5d1, 2d7, 1i1(G), 6 h, 1WT 8+: 10−
 #10 Bi-allele 7d254, 3d6 6d254, 4d6, 6 h 15+: 3−
 #17 Chimera 2WT, 2d1a, 1d1b, 1i1(C) NT NT
 #12 Chimera 10WT, 1d3, 1i1(T) NT NT
 #4 WT 12WT NT NT
 #7 Chimera 4d66, 3d12, 3d18, 3d48 NT NT
 #11 Bi-allele 5d2, 3d1 NT NT
 #33 Hetero 2WT, 1i1(T) NT NT
 #52 Chimera 4WT, 3i1(G), 2d9 NT NT
Total homozygote plant 
(-CRISPR/Cas9) 39 (13)
TG3C37
 #21 Chimera 4d53, 4i1(T), 1d11 4i1(T), 3d53, 17 h 15+: 11−
 #3 Bi-allele 6d4, 2(d6i1) 4d4, 3(d6i1), 13 h 12+: 9−
 #4 Bi-allele 9i1(A), 2i1(T) 7i1(T), 6i1(A), 6 h 15+: 8−
 #6 Bi-allele 4i1(T), 1i1(G) 5i1(G), 3i1(T), 11 h 19+: 1−
 #15 Chimera 6i1(T), 1d1i1, 1d27 NT NT
 #10 Bi-allele 4d3, 3i1(T) NT NT
 #8 Bi-allele 5i1(T), 3d3 NT NT
 #23 Bi-allele 2d6, 2d123 NT NT
 #9 Bi-allele 4d6, 3d3 NT NT
Total homozygote plant 
(-CRISPR/Cas9) 35 (12)
Table 1. CRISPR/Cas9-induced mutations in target genes. The zygosities, such as homozygote, bi-allele and 
heterozygote, were estimated on T0 plant. WT, wild-type sequence with no mutation detected. “d” and “i” mean 
deletion and insertion, respectively. (A,T,G,C) after “i” indicated the inserted base pair. “il (T) means “T” was 
inserted on target site. In T0 generation, “d#” or “i#” is # of base pair were deleted or were inserted on target 
site. Numbers before “d” or “i” mean the number of clones we checked. “d1i1” means 1 bp was deleted and 
inserted at the same time. “a” and “b” in Superscript mean different type of 1 base pair deletion. In T1 generation, 
numbers before “d” or “i” means plant number with mutation in each lines. All “d” and “i” are homozygous. “h” 
is heterozygous. “NT” means not-tested. “+” and “−” are with or without T-DNA insertion. The number before 
“+” or “−” is plant numbers.
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Line Genotype Amino acid sequence
GAD2 WT DIV(10aa)RVKAKLAVAEEAAAANGIDSVAHHKTDREWELQVTEAWKKFVADKKKNKTMGVC* Type of 
C-terminal GABATG2C30
#17
d3 DIV(10aa)RVKAKLAVAEEAAAANGIDSVAHH-TDREWELQVTEAWKKFVADKKKNKTMGVC*
3 Higher
d50 DIV(10aa)RVKAKLAVAEEAAAANGIDSVEEVCC*
#9
WT DIV(10aa)RVKAKLAVAEEAAAANGIDSVAHHKTDREWELQVTEAWKKFVADKKKNKTMGVC*
3 Higherd3 DIV(10aa)RVKAKLAVAEEAAAANGIDSVAHQ-TDREWELQVTEAWKKFVADKKKNKTMGVC*
i1(A) DIV(10aa)RVKAKLAVAEEAAAANGIDSVAHHKNG*
#13
WT DIV(10aa)RVKAKLAVAEEAAAANGIDSVAHHKTDREWELQVTEAWKKFVADKKKNKTMGVC*
2 Higherd3 DIV(10aa)RVKAKLAVAEEAAAANGIDSVAHH-TDREWELQVTEAWKKFVADKKKNKTMGVC*
d1 DIV(10aa)RVKAKLAVAEEAAAANGIDSVAHHKRIENGSYRLLKHGRSLLLIKRRIRLWEFVN*
#24 d3 DIV(10aa)RVKAKLAVAEEAAAANGIDSVAHQ-TDREWELQVTEAWKKFVADKKKNKTMGVC* 2 Same
#10
d3 DIV(10aa)RVKAKLAVAEEAAAANGIDSVAHQ-TDREWELQVTEAWKKFVADKKKNKTMGVC*
2 Same
d1 DIV(10aa)RVKAKLAVAEEAAAANGIDSVAHHKRIENGSYRLLKHGRSLLLIKRRIRLWEFVN*
#14 d1 DIV(10aa)RVKAKLAVAEEAAAANGIDSVAHHKRIENGSYRLLKHGRSLLLIKRRIRLWEFVN* 2 Same
#27 d4 DIV(10aa)RVKAKLAVAEEAAAANGIDSVAH-KRIENGSYRLLKHGRSLLLIKRRIRLWEFVN* 2 Same
#4 d4 DIV(10aa)RVKAKLAVAEEAAAANGIDSVAH-KRIENGSYRLLKHGRSLLLIKRRIRLWEFVN* 2 Same
#5 d4 DIV(10aa)RVKAKLAVAEEAAAANGIDSVAH-KRIENGSYRLLKHGRSLLLIKRRIRLWEFVN* 2 N.D.
#7
d3 DIV(10aa)RVKAKLAVAEEAAAANGIDSVAH-KTDREWELQVTEAWKKFVADKKKNKTMGVC*
3 N.D.
d2 DIV(10aa)RVKAKLAVAEEAAAANGIDSVAHQNG*
#18
d3 DIV(10aa)RVKAKLAVAEEAAAANGIDSVAHQ-TDREWELQVTEAWKKFVADKKKNKTMGVC*
3 N.D.
i1(A) DIV(10aa)RVKAKLAVAEEAAAANGIDSVAHHKNG*
GAD2 WT DIV(10aa)RVKAKLAVAEEAAAANGIDSVAHHKTDREWELQVTEAWKKFVADKKKNKTMGVC* Type of 
C-terminal GABATG2C48
#56
WT DIV(10aa)RVKAKLAVAEEAAAANGIDSVAHHKTDREWELQVTEAWKKFVADKKKNKTMGVC*
3 Higher
d1 DIV(10aa)RVKAKLPWPRRRPRRTVSTAWHIIKRIENGSYRLLKHGRSLLLIKRRIRLWEFVN*
i1(G) DIV(10aa)RVKAKLGRGRGGGRGERYRQRGTS*
d5 DIV(10aa)RVKASRGRGGGRGERYRQRGTS*
#57
d43 DIV(10aa)RTVSTAWHIIKRIENGSYRLLKHGRSLLLIKRRIRLWEFVN*
3 Higher
d7 DIV(10aa)RVKAPWPRRRPRRTVSTAWHIIKRIENGSYRLLKHGRSLLLIKRRIRLWEFVN*
d2 DIV(10aa)RVKAKLRGRGGGRGERYRQRGTS*
i1(A) DIV(10aa)RVKAKLDRGRGGGRGERYRQRGTS*
#13
WT DIV(10aa)RVKAKLAVAEEAAAANGIDSVAHHKTDREWELQVTEAWKKFVADKKKNKTMGVC*
3 Higher
i1(G) DIV(10aa)RVKAKLGRGRGGGRGERYRQRGTS*
#17
WT DIV(10aa)RVKAKLAVAEEAAAANGIDSVAHHKTDREWELQVTEAWKKFVADKKKNKTMGVC*
3 Higher
d1a DIV(10aa)RVKAKLPWPRRRPRRTVSTAWHIIKRIENGSYRLLKHGRSLLLIKRRIRLWEFVN*
d1b DIV(10aa)RVKAKLAWPRRRPRRTVSTAWHIIKRIENGSYRLLKHGRSLLLIKRRIRLWEFVN*
i1(C) DIV(10aa)RVKAKLARGRGGGRGERYRQRGTS*
#12
WT DIV(10aa)RVKAKLAVAEEAAAANGIDSVAHHKTDREWELQVTEAWKKFVADKKKNKTMGVC*
3 Higherd3 DIV(10aa)RVKAKP-VAEEAAAANGIDSVAHHKTDREWELQVTEAWKKFVADKKKNKTMGVC*
i1(T) DIV(10aa)RVKAKLVRGRGGGRGERYRQRGTS*
#10
d6 DIV(10aa)RVKA--TVAEEAAAANGIDSVAHHKTDREWELQVTEAWKKFVADKKKNKTMGVC*
4 Same
d254 DIV*
#4 WT DIV(10aa)RVKAKLAVAEEAAAANGIDSVAHHKTDREWELQVTEAWKKFVADKKKNKTMGVC* — Same
#7
d12 DIV--(13aa)----TVAEEAAAANGIDSVAHHKTDREWELQVTEAWKKFVADKKKNKTMGVC*
2 Same
d18 DIV(10aa)RVKAK------AAAANGIDSVAHHKTDREWELQVTEAWKKFVADKKKNKTMGVC*
d48 DIV-6AA-------------AAAANGIDSVAHHKTDREWELQVTEAWKKFVADKKKNKTMGVC*
d66 DIVKVLHELD-----------------NSVAHHKTDREWELQVTEAWKKFVADKKKNKTMGVC*
#11
d1 DIV(10aa)RVKAKLPWPRRRPRRTVSTAWHIIKRIENGSYRLLKHGRSLLLIKRRIRLWEFVN*
3 n.d.
d2 DIV(10aa)RVKAKLRGRGGGRGERYRQRGTS*
#33
WT DIV(10aa)RVKAKLAVAEEAAAANGIDSVAHHKTDREWELQVTEAWKKFVADKKKNKTMGVC*
3 n.d.
i1(T) DIV(10aa)RVKAKLGRGRGGGRGERYRQRGTS*
#52
WT DIV(10aa)RVKAKLAVAEEAAAANGIDSVAHHKTDREWELQVTEAWKKFVADKKKNKTMGVC*
3 n.d.i1(G) DIV(10aa)RVKAKLGRGRGGGRGERYRQRGTS*
d9 DIV(10aa)RVKA---VAEEAAAANGIDSVAHHKTDREWELQVTEAWKKFVADKKKNKTMGVC*
Continued
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Relationship between C-terminal mutation types and GABA accumulation in T0. The muta-
tion types of the C-terminal were reflected in the GABA accumulation levels of the T0 generation (Table 2, 
Supplementary Fig. 2). Type 1 and Type 3 mutants showed higher GABA accumulation whereas Type 2 and Type 
4 mutants showed similar levels to the WT. These results indicated that a truncated C-terminal region immedi-
ately upstream of the autoinhibitory domain effectively increased GABA accumulation.
Genotype and zygosity in T1 plants. The zygosity and genotype of target sites in the T1 generation were 
examined as previously described34. Since this method used PCR product of target site and sequencing directly, 
homozygotic and WT genotypes was clearly identified whereas bi-allelic, heterozygous, and chimeric lines were 
not (identified as ‘h’ in Table 1). Six TG2C30 (#9, #13, #14, #17, #24, and #27), four TG2C48 (#13, #10, #56, and 
#57), and four TG3C37 (#3, #4, #6, and #21) lines that exhibited high GABA levels in the T0 generation and/or 
had enough seeds were used for experiments. Among these lines, 44.0% (107/243) were homozygotes, 15.2% 
(37/243) were WT, and 40.7% (99/243) were ‘h’. The 107 homozygous T1 plants had three genotypes: deletion 
ranging from a single to more than 200 nucleotides (66.4%, 71/107), single-nucleotide insertion (30.8%, 33/107), 
and simultaneous insertion and deletion (2.8%, 3/107).
Structure of GADs C-terminal in the homozygous mutant line of T1. Amino acid sequences of 
mutation lines in T1 homozygous are summarized in Table 3. Because all of these plants were homozygous, 
the structure of their C-terminal was classified into Type 1 or Type 2; this was further divided in two groups: 
C-terminal Type 2a had a conserved autoinhibitory domain and Type 2b was a defective autoinhibitory domain 
in C-terminal, which had almost the same size as that of WT (Supplementary Fig. 3). The most frequent mutation 
was Type 1 (21/38 plants), the second was Type 2a (10/38 plants), and the rarest was Type 2b (7/38 plants). Type 
frequency differed according to the target site. In TG2C30, the most frequent mutation was Type 2a (5/7 plants), 
in TG2 C48 it was Type 2b (7/17 plants), and in TG3C37 it was Type 1 (all plants).
Plant size, flowering, and fruit yield in the T1 generation. The phenotype of 38 homozygous plants 
from six lines whose red-stage fruit showed high GABA content in T0 (Fig. 2) were analyzed in the T1 genera-
tion. This included 22 plants that were null CRISPR/Cas9 segregates. All TG2C30, TG2C48, and TG3C37 plants 
except for TG2C30 (genotype d50; #17-2, #17-4) and TG2C48 (genotype i1; #56-6, #56-18, #56-19, #56-24, #13-
6) were slightly smaller than WT (Fig. 3 and Table 4). A similar trend was observed in the TG2C30 lines (#9-3, 
#9-5, #9-7) with the WT genotype. All of these lines were produced by regeneration, which could affect plant size 
in the T1 generation. TG2C30 (genotype d50; #17-2, #17-4) and TG2C48 (genotype i1; #56-6, #56-18, #56-19, 
Line Genotype Amino acid sequence
GAD3 WT TLADRLVSDIVKVLHELPNAKKVEDNLMINNEKKTEIEVQRAIAEFWKKYVLARKASIC* Type of 
C-terminal GABATG3C37
#21
i1(T) TLADRLVSDIVKVLHELPNAKKVGG*
1 Higherd11 TLADRLVSDIVKVLHELPNAK*
d53 TLADRLVSDIVKVLHELPN*
#3
d4 TLADRLVSDIVKVLHELPNAKWRII*
1 Higher
d5 TLADRLVSDIVKVLHELPNAIGG*
#4
i1(A) TLADRLVSDIVKVLHELPNAKKDGG*
1 Higher
i1(T) TLADRLVSDIVKVLHELPNAKKVGG*
#6
i1(T) TLADRLVSDIVKVLHELPNAKKVGG*
1 Higher
i1(G) TLADRLVSDIVKVLHELPNAKKVGG*
#15
d1+ i1 TLADRLVSDIVKVLHELPNAKKLEDNLMINNEKKTEIEVQRAIAEFWKKYVLARKASIC*
3 Higherd27 TLADRLVSDIVKVLHELPNA---------NNEKKTEIEVQRAIAEFWKKYVLARKASIC*
i1(T) TLADRLVSDIVKVLHELPNAKKVGG*
#10
d3 TLADRLVSDIVKVLHELPNAK-MEDNLMINNEKKTEIEVQRAIAEFWKKYVLARKASIC*
3 Higher
i1(T) TLADRLVSDIVKVLHELPNAKKVGG*
#8
d3 TLADRLVSDIVKVLHELPNAK-VEDNLMINNEKKTEIEVQRAIAEFWKKYVLARKASIC*
3 Higher
i1(T) TLADRLVSDIVKVLHELPNAKKVGG*
#23
d6 TLADRLVSDIVKVLHELPNAK--EDNLMINNEKKTEIEVQRAIAEFWKKYVLARKASIC*
4 Same
d123 TLADRWKKYVLARKASIC*
#9
d3 TLADRLVSDIVKVLHELPNAK-MEDNLMINNEKKTEIEVQRAIAEFWKKYVLARKASIC*
2 Same
d6 TLADRLVSDIVKVLHELPNA--MEDNLMINNEKKTEIEVQRAIAEFWKKYVLARKASIC*
Table 2. Amino acid sequence of Target site (T0 generation). WT, wild-type sequence with no mutation detected. 
“d” and “i” means deletion and insertion, respectively. “*” was stop codon. The same sequence as Wild Type is 
expressed in Bold. The changed sequence by the mutation via CRISPR/Cas9 was in Regular. Bold with underline 
is the putative auto inhibitory domain and CaMd domain. The target site is in Italic. “a” and “b” in Superscript 
mean different one base-pair deletion. “Higher” showed higher GABA content comparing with WT. “Same level” 
indicated almost the same contain level as WT. n.d. means no data. GABA content was measured using fruits at 
the Br + 10 stage (red).
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#56-24, #13-6) plants were remarkably small (Table 4). Flowering was delayed in TG2C48 (#56-19), and there 
were no flower buds produced by TG2C30 (genotype d50; #17-2 and #17-4) and TG2C48 (genotype i1; #56-6, 
#56-18, #56-19, #56-24, and #13-6). Differences in the flowering were not observed between the TG2C30 (gen-
otype d3; #17-1, #17-3), TG2C48 (genotype d1; #13-3, #13-4, #13-14, #13-17 and genotype d7; #13-9, #13-16, 
#13-18), all lines of TG3C37 and WT lines (Table 4). Red-stage (Breaker +10 days) fruit number per plant in the 
TG2C30 (genotype d3; #17-1, #17-3), TG2C48 (genotype d1; #13-3, #13-9, #13-14, #13-17, #13-18), and all lines 
of TG3C37 was almost the same as WT (Table 4), and red-stage fruit size was similar to or slightly larger than 
WT (Supplemental Fig. 4). Thus, fruit yield was not significantly affected in these lines. On the other hand, fruit 
number was low in TG2C30 (genotype d50; #17-2, #17-4) and TG2C48 (Genotype i1; #56-6, #56-18, #56-19, 
#56-24, #13-6) relative to WT.
Figure 2. GABA content of T0 red-stage tomato fruits. GABA content was measured by the GABase enzymatic 
method using fruits at the Breaker-stage +10 days in the T0 generation. Mutations were detected at the target 
site of CRISPR/Cas9 in all lines. Bars indicate standard deviation (n = 3) and asterisks statistical differences 
according to the Tukey-Kramer’s test between mutated and control lines (*P < 0.05 and **P < 0.01). ‘C’ 
indicates the control plant with wild type (WT) genotype. (a,b and c) show GABA content in TG2C30, TG2C48, 
and TG3C37 mutated lines, respectively.
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GABA accumulation in leaves of T1 plants. Plant size was markedly reduced in TG2 C30 (genotype 
d50; #17-2 and #17-4) and TG2C48 (genotype i1; #56-6, #56-18, #56-19, #56-24, and #13-6) (Fig. 3 and Table 4). 
Previous studies in Arabidopsis thaliana reported that GABA accumulation affected cell elongation and decreased 
plant size35. Accordingly, we speculated that the observed reduction in plant size was caused by high GABA 
Line Genotype Amino sequence
GAD2 WT DIV-10AA-RVKAKLAVAEEAAAANGIDSVAHHKTDREWELQVTEAWKKFVADKKKNKTMGVC*
Type of C-terminal GABA
TG2C30
#17-2 d50 DIV-10AA-RVKAKLAVAEEAAAANGIDSVEEVCC*
1 Higher
#17-4 d50 DIV-10AA-RVKAKLAVAEEAAAANGIDSVEEVCC*
#17-1 d3 DIV-10AA-RVKAKLAVAEEAAAANGIDSVAHH-TDREWELQVTEAWKKFVADKKKNKTMGVC*
2a Same
#17-3 d3 DIV-10AA-RVKAKLAVAEEAAAANGIDSVAHH-TDREWELQVTEAWKKFVADKKKNKTMGVC*
#9-3 WT DIV-10AA-RVKAKLAVAEEAAAANGIDSVAHHKTDREWELQVTEAWKKFVADKKKNKTMGVC*
2a Same#9-5 WT DIV-10AA-RVKAKLAVAEEAAAANGIDSVAHHKTDREWELQVTEAWKKFVADKKKNKTMGVC*
#9-7 WT DIV-10AA-RVKAKLAVAEEAAAANGIDSVAHHKTDREWELQVTEAWKKFVADKKKNKTMGVC*
GAD2 WT DIV-10AA-RVKAKLAVAEEAAAANGIDSVAHHKTDREWELQVTEAWKKFVADKKKNKTMGVC*
Type of C-terminal GABA
TG2C48
#13-6 i1 DIV-10AA-RVKAKLGRGRGGGRGERYRQRGTS* 1 Higher
#56-6 i1 DIV-10AA-RVKAKLGRGRGGGRGERYRQRGTS*
1 Higher
#56-18 i1 DIV-10AA-RVKAKLGRGRGGGRGERYRQRGTS*
#56-19 i1 DIV-10AA-RVKAKLGRGRGGGRGERYRQRGTS*
#56-24 i1 DIV-10AA-RVKAKLGRGRGGGRGERYRQRGTS*
#13-1 WT DIV-10AA-RVKAKLAVAEEAAAANGIDSVAHHKTDREWELQVTEAWKKFVADKKKNKTMGVC* 2a Same
#56-1 WT DIV-10AA-RVKAKLAVAEEAAAANGIDSVAHHKTDREWELQVTEAWKKFVADKKKNKTMGVC*
2a Same#56-13 WT DIV-10AA-RVKAKLAVAEEAAAANGIDSVAHHKTDREWELQVTEAWKKFVADKKKNKTMGVC*
#56-17 WT DIV-10AA-RVKAKLAVAEEAAAANGIDSVAHHKTDREWELQVTEAWKKFVADKKKNKTMGVC*
#56-12 d27 DIV-10AA----------EEAAAANGIDSVAHHKTDREWELQVTEAWKKFVADKKKNKTMGVC* 2a Same
#13-4 d7 DIV-10AA-RVKAPWPRRRPRRTVSTAWHIIKRIENGSYRLLKHGRSLLLIKRRIRLWEFV*
2b Lower
#13-16 d7 DIV-10AA-RVKAPWPRRRPRRTVSTAWHIIKRIENGSYRLLKHGRSLLLIKRRIRLWEFV*
#13-3 d1 DIV-10AA-RVKAKLPWPRRRPRRTVSTAWHIIKRIENGSYRLLKHGRSLLLIKRRIRLWEFV*
2b Lower
#13-9 d1 DIV-10AA-RVKAKLPWPRRRPRRTVSTAWHIIKRIENGSYRLLKHGRSLLLIKRRIRLWEFV*
#13-14 d1 DIV-10AA-RVKAKLPWPRRRPRRTVSTAWHIIKRIENGSYRLLKHGRSLLLIKRRIRLWEFV*
#13-17 d1 DIV-10AA-RVKAKLPWPRRRPRRTVSTAWHIIKRIENGSYRLLKHGRSLLLIKRRIRLWEFV*
#13-18 d1 DIV-10AA-RVKAKLPWPRRRPRRTVSTAWHIIKRIENGSYRLLKHGRSLLLIKRRIRLWEFV*
GAD3 WT TLADRLVSDIVKVLHELPNAKKVEDNLMINNEKKTEIEVQRAIAEFWKKYVLARKASIC*
Type of C-terminal GABA
TG3C37
#21-1 i1 TLADRLVSDIVKVLHELPNAKKVGG*
1 Higher
#21-5 i1 TLADRLVSDIVKVLHELPNAKKVGG*
#21-7 i1 TLADRLVSDIVKVLHELPNAKKVGG*
#21-16 i1 TLADRLVSDIVKVLHELPNAKKVGG*
#21-18 d53 TLADRLVSDIVKVLHELPN*
1 Higher#21-19 d53 TLADRLVSDIVKVLHELPN*
#21-26 d53 TLADRLVSDIVKVLHELPN*
#3-1 d6i1 TLADRLVSDIVKVLHELPNAIGG*
1 Higher#3-6 d6i1 TLADRLVSDIVKVLHELPNAIGG*
#3-8 d6i1 TLADRLVSDIVKVLHELPNAIGG*
#3-4 d4 TLADRLVSDIVKVLHELPNAKWRII*
1 Higher
#3-10 d4 TLADRLVSDIVKVLHELPNAKWRII*
#3-12 d4 TLADRLVSDIVKVLHELPNAKWRII*
#3-13 d4 TLADRLVSDIVKVLHELPNAKWRII*
Table 3. Amino acid sequence of Target site (T1 generation). Genotype of all plants in this table were 
homozygous. WT, wild-type sequence with no mutation detected. “d” and “i” means deletion and insertion, 
respectively. “*” was stop codon. The same sequence as Wild Type is expressed in Bold. The changed sequence 
by the mutation via CRISPR/Cas9 was in Regular. Bold with underline is the putative auto inhibitory domain 
and CaMd domain. The target site is in Italic. “a” and “b” in Superscript mean different one base-pair deletion. 
“Higher” meant higher GABA content comparing with WT. “Lower” shows lower GABA content than WT. 
“Same level” indicated almost the same contain level as WT. GABA content was measured by HPLC, using leaf 
(TG3C30 and TG2C48) and fruits at the Br + 10 stage (red) (TG3C37).
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levels. To verify this possibility, we measured the GABA content in leaves by high-performance liquid chro-
matography (HPLC). TG2C30 (genotype d50; #17-2, #17-4) and TG2C48 (genotype i1; #56-6, #56-18, #56-19, 
#56-24, #13-6) had 16.5- to 36-fold higher GABA levels than WT plants, with the highest value corresponding to 
179.01 ± 25.16 mg/100 g FW (Fig. 4b). On the other hand, TG2C48 (genotype d1; #13-3, #13-4, #13-14, #13-17 
and genotype d7; #13-9, #13-16, #13-18) had levels that were lower than that of the WT. GABA content in the 
other lines TG2C30 (genotype d3; #17-1, #17-3), TG2C48 (genotype d1; #13-3, #13-9, #13-14, #13-17, #13-18), 
and all lines of TG3C37 were comparable to that in WT (Fig. 4). Only lines that had a smaller plant size had high 
GABA levels in the leaves; this was associated with decreased flowering and fruit yield.
Correlation between GAD C-terminal structure and GABA accumulation. The structure of the 
C-terminal was correlated with GABA accumulation (Table 3, Supplementary Fig. 3). Type 1 mutants with the 
truncated C-terminal had higher GABA accumulation than the WT, whereas Type 2a mutants, with the con-
served autoinhibitory domain, had a similar GABA accumulation to that of the WT; Type 2b showed a reduced 
GABA accumulation. These results indicated that the truncation of the autoinhibitory domain in the C-terminal 
region (Type 1) increased GABA accumulation, and that in Type 2b the presence of additional meaningless amino 
acids strongly reduced GABA accumulation.
GABA accumulation in red-stage fruits of T1 plants. TG3C37 included only Type 1 mutants with 
potentially higher GABA content. We examined the effect of this mutation in red-stage (Breaker +10 days) 
fruit suitable for harvest by HPLC analysis of GABA levels. All TG3C37 lines had greater-than-WT GABA 
accumulation. TG3C37 #3 produced seven to 15 times more GABA than WT plants, with a maximum value of 
125.73 ± 6.17 mg/100 g FW (Fig. 5). GABA accumulation in TG3C37 #21 was 8.75 to 11.6 times higher than in WT, 
with the highest value being 97.84 ± 17.46 mg/100 g FW (Fig. 5). All of the lines with high GABA content in the 
fruit had a stop codon immediately upstream of the autoinhibitory domain and close to C37 (ΔC34, ΔC36, and 
ΔC40). Taken together with the results of the in vitro enzyme assay of SlGAD3ΔC37 (Fig. 1c), we conclude that 
C-terminal truncation of SlGAD3 increases enzymatic activity, leading to GABA accumulation in the tomato fruit.
Figure 3. Plant size in 25-week-old plants in the T1 generation. All plants were homozygous. Genotype ‘WT’ 
was identical to that of wild type, as no mutation was detected. ‘d’ and ‘i’ indicate deletion and insertion, 
respectively. Line ‘WT’ indicates a wild type plant. White bars correspond to 5 cm.
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Discussion
Our results found that SlGAD2 and SlGAD3 lacking the C-terminal had an increased activity (Fig. 1b,c). Thus, 
the C-terminal of SlGAD2 also includes the autoinhibitory domain, and tomato has at least two kinds of active 
GADs. The activity of SlGAD2 is almost 10 times higher than that of SlGAD3 at pH 5.8 (Fig. 1b,c). The alignment 
of SlGAD2 and SlGAD3 amino acid sequences (Supplementary Fig. 5) showed these are well conserved, except 
for the C-terminal region, as SlGAD2 presented additional sequence immediately upstream of autoinhibitory 
domain compared to SlGAD3. In apple (Malus domestica), MdGAD1 showed higher activity than MdGAD236 
and MdGAD1 also had additional sequence immediately upstream of the autoinhibitory domain (Supplementary 
Fig. 6). These results suggest that this additional sequence immediately upstream of the autoinhibitory domain 
might affect the strength of GAD activity.
The correlation between the C-terminal mutation Types and GABA accumulation was observed in the T0 
generation (Table 2, Supplementary Fig. 2). It was found through the analysis of the Types of C-terminal muta-
tion and GABA accumulation that at least one truncated C-terminal effectively increased GABA accumulation. 
This means that heterozygous GADs with truncated C-terminal might increase GABA accumulation in the T0 
generation. In tomato breeding, F1 hybrids are frequently used. The analysis of the C-terminal in the T0 gen-
eration and GABA accumulation suggested that the F1 hybrid lines would exhibit high GABA content. Thus, 
either parental line with a truncated GAD C-terminal introduced by CRISPR/Cas9 may be effectively used for 
high-GABA-content tomato breeding.
The result of our experiment, in T1 generation, clearly showed that completely removal of the C-terminal 
region (Type 1) increased the GABA accumulation and defective C-terminal (Type 2b) caused the reduction 
(Table 3, Supplementary Fig. 4). The C-terminal has functions for autoinhibitory domain activated via Ca2+/
CaM20, 21, 37. Thus, our results suggest that although the removal of the C-terminal increased GAD activity21 
(Fig. 1a), deficiencies in this domain would lead to the complete loss of GAD activity and reduce GABA accu-
mulation in tomato. In cell environmental conditions, i.e., at pH 7.0, the C-terminal of GAD works as ‘cover’ for 
the active site of the enzyme, but under GABA-required conditions, such as response to biotic or abiotic stresses 
and growth and development, the autoinhibitory domain is released via the active site is uncover via Ca2+/CaM 
binding20, 37. Our study suggests that lines with the defective C-terminal (Type 2b) might have lost the function of 
Ca2+/CaM binding, keeping the active site ‘covered’, resulting in low GABA accumulation.
SlGAD2 with lacking the C terminus (Type 1) suppressed plant growth, flowering, and fruit yield (Table 4), 
which was associated with abnormally high GABA levels in the leaves. In contrast, SlGAD3 with truncation of C 
terminal (Type 1) showed leaf GABA accumulation that was comparable to WT. The effect of this mutation on 
plant size was less than that of SlGAD2 lacking the C terminus. Moreover, this mutation increased GABA accu-
mulation in fruits without decreasing flowering and fruit yield (Fig. 3 and Table 4). We therefore conclude that 
SlGAD3 is a more suitable CRISPR/Cas9 target site than SlGAD2 for increasing GABA levels in tomato fruits. The 
differential effects of mutations in the two genes are likely due to their distinct expression patterns: SlGAD2 and 
SlGAD3 were most highly expressed in leaves and in fruits, respectively (Supplemental Fig. 7).
Remarkably smaller plant size in TG2C30 (genotype d50) and TG2C48 (genotype i1) with (Type 1) was caused 
by increased GABA accumulation in leaves (Fig. 4a,b). Altered concentrations of GABA and related metabolites 
in vivo can lead to severe developmental defects such as short stems caused by the failure of parenchyma cell 
elongation21–23. GAD is the entry enzyme of the GABA shunt that catalyses the decarboxylation of glutamic 
Line Genotype
Plant 
Number
Fruit 
Number
Days until 
flowering (Days) Height (mm)
GABA accumulation (mg/gFW)
Leaf Fruit
WT 5 51< 49.7 ± 2.0 99.2 ± 6.6 4.9 ± 0.92 (n = 15) 10.04 ± 2.0 (n = 15)
TG2C30
9 WT 13 112< 64.5 ± 6.3 88.1 ± 7.2 2.79 ± 0.58 (n = 9) n.t.
17
d3 2 21< n.t. n.t. 2.9 ± 1.86 (n = 6) n.t.
d50 2 0 n.t. n.t. 98.2 ± 24.31** (n = 6) n.t.
TG2C48
56
WT 6 57< 57.7 ± 4.6 92.8 ± 5.3 3.8 ± 1.43 (n = 9) n.t.
i1 4 4 85.0 ± 7.4** 63.6 ± 6.8* 130.62 ± 41.03** (n = 12) n.t.
d27 1 13< n.t. n.t. 3.92 ± 1.07 (n = 3) n.t.
13
WT 1 9< n.t. n.t. 2.05 ± 0.86 (n = 3) n.t.
d1 5 60< 52.6 ± 3.4 77.4 ± 2.3 0.32 ± 0.11† (n = 15) n.t.
d7 2 20< n.t. n.t. 0.31 ± 0.12† (n = 6) n.t.
i1 1 0 n.t. n.t. 139.55 ± 44.65** (n = 3) n.t.
TG3C37
21
i1 4 37< 74.5 ± 3.5 108.9 ± 7.1 5.18 ± 2.26 (n = 12) 78.0 ± 11.31** (n = 12)
d53 3 28< 57.3 ± 10.0 96.0 ± 6.2 5.27 ± 1.00 (n = 9) 88.72 ± 15.9** (n = 9)
3
d4 4 38< 50.0 ± 5.4 77.2 ± 4.1 3.77 ± 1.77 (n = 12) 78.75 ± 20.75** (n = 12)
d6i1 3 26< 63.3 ± 10.4 71.8 ± 7.3 3.17 ± 0.75 (n = 9) 94.94 ± 32.44 (n = 9)
Table 4. Characterization of T1 generation. Genotype of all plants in this table were homozygous. In 
“Genotype”, WT was same as wild-type sequence with no mutation detected. “d” and “i” means deletion and 
insertion, respectively. In column of “Days until flowering” and “Height”, data represent means ± SD, the 
repetition was same as plant number. GABA content data showed means ± SD (repetition). Asterisk and dagger 
indicated statistical differences in Tukey-Kramer’s test and Student’s t-test (*P > 0.05, **P > 0.01, †P > 0.01), 
respectively. “n.t.” was non-tested.
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acid (Glu) to GABA38; increasing this activity can lead to a major change in carbon-nitrogen (C-N) balance that 
favours N23. Moreover, high levels of GABA in A. thaliana decreased the expression of genes encoding secreted 
and cell wall-related proteins35. SlGAD2 activation via removal of the autoinhibitory domain may thus enhance 
Glu-to-GABA decarboxylation and alter C-N balance, and high GABA content in leaves could inhibit the expres-
sions of genes related to cell elongation, thereby decreasing plant size.
The CRISPR/Cas9 system is more effective than the TILLING platform for introducing mutations at specific 
sites, for instance in the 30–50 amino acids of the SlGAD C terminus. In tomato, 0.5% and 1.0% EMS populations 
harbour one mutation per 1,710 and 737 kb, respectively. The overall mutation frequency (one mutation per 
1,237 kb)24 affects an average of three alleles per screened kilobase; thus, the TILLING platform is more useful 
for screening relatively wide regions within the genome. In a previous study using 4,588 lines of EMS mutant 
alleles, we isolated a GAD mutant with the TILLING platform (Ezura et al., unpublished data). Although lines 
with four SlGAD2 and two SlGAD3 mutations were identified, each mutation was located around the N terminus 
of SlGAD2 or SlGAD3. SlGAD2 and SlGAD3 genes are 6.7 kb and 2.0 kb, respectively; given the average mutation 
frequency, we likely isolated the maximum number of mutant lines for each gene, and it would have been diffi-
cult to isolate SlGAD2ΔC and SlGAD3ΔC in these EMS populations using the TILLING platform. The present 
study showed that screening 14 to 35 transgenic lines with the CRISPR/Cas9 vector was sufficient to introduce 
Figure 4. Leaf GABA content in the T1 generation. GABA content of leaves was measured by HPLC. All lines 
were homozygous. Bars indicate standard deviation (n = 3) and asterisks indicate statistical differences in 
relation to control according to the Tukey-Kramer’s test (*P < 0.05 and **P < 0.01). ‘C’ is the control plant with 
WT genotype. (a,b and c) show GABA content in TG2C30, TG2C48, and TG3C37 mutated lines, respectively.
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mutations at the C terminus of SlGADs, demonstrating its superiority for introducing site-specific or small-area 
mutations.
Transgenic strategies have been employed to increase GABA accumulation in tomato fruits18, 19. Although 
overexpressing full-length SlGAD3 containing 155 mg/100 g FW GABA did not affect fruit ripening, overex-
pressing SlGAD3 lacking the C terminus (268 mg/100 g FW) inhibited the development of fruits with a red-ripe 
coloration from those with an orange colour19. From these previous results, we estimated that the maximum 
concentration of GABA in a normal ripe fruit is 155 mg/100 g FW. The targeted mutagenesis through the CRISPR/
Cas9 system deleted the autoinhibitory domain of C-terminal in SlGAD3 and increased the GABA accumulation 
up to 125 mg/100 g FW (15 times higher than WT) in fruit with normal-red ripening. This result means that the 
targeted mutagenesis is useful strategy to increase GABA accumulation as well as transgenic. Regarding breed-
ing, the application of mutagenesis would be more acceptable than transgenesis. Because after the segregation of 
CRISPR/Cas9 vector, it would be un-distinguished the product via conventional mutation technique and targeted 
mutagenesis. Therefore, inducing a mutation in the C-terminal of SlGAD3 via CRISPR/Cas9 seems to be a more 
useful method than the transgenic strategy with respect to both fruit phenotype and public acceptance in near 
feature.
We succeeded in producing a high-GABA-accumulation tomato line (up to 125 mg/100 g FW in red ripe 
tomato fruits) using the targeted mutagenesis through the CRISPR/Cas9 system. The daily intake of 10–20 mg of 
GABA effectively reduces blood pressure in adults with mild hypertension11, 39, 40. This amount of GABA is equiv-
alent to the level present in 10–20 g FW of C-terminal-removed tomato, which corresponds to 3–6 ‘Micro-Tom’ 
fruits and to one-tenth of a large tomato fruit. Therefore, the removal of SlGAD3 C-terminal by targeted mutagen-
esis seems to be sufficient to increase GABA accumulation and for promoting health.
The removal of the C-terminal in GADs increased their activity in many plant species, such as petunia, rice, 
and tomato19, 22, 41, and the overexpression of truncated C-terminal in GADs remarkably increased GABA accu-
mulation in tobacco, rice, A. thaliana, and tomato19, 21–23. In apple, the activity of MdGAD1 and MdGAD2 is 
regulated by their C-terminal with a Ca2+/CaM binding site36. In the present study, the mutation introduced into 
the C-terminal of SlGADs, which regulates their enzymatic activity42, 43, using the targeted mutagenesis, CRISPR/
Cas9 system, produced high-GABA-accumulation tomato line. Thus, removing the C-terminal of GAD effectively 
increases GABA accumulation in a wide variety of crops. Therefore, our study suggests that the utilization of 
targeted mutagenesis targeting the C-terminal of GADs would be effective to breed high-GABA-accumulation 
varieties in wide range of crops. This strategy might contribute to recover from diseases associated with lifestyle, 
such as high blood pressure, via dietary products.
Methods
Plant materials and growth conditions. Tomato (Solanum lycopersicum L.) ‘Micro-Tom’ seeds were 
provided by the National Bioresource Project15. Seeds of WT and T1 generation were germinated on moistened 
filter paper, transplanted into soil, and grown in a culture room at 25 °C, under fluorescent light (60 µmol/m2/s) 
in a 16:8 h light:dark photoperiod. A standard nutrient solution (Otsuka A; Otsuka Chemical Co., Ltd, Osaka, 
Japan) was supplied. Plant height was measured on the first flowering day. Leaves were sampled during vegetative 
growth. Fruits were harvested 10 days after the Breaker-stage.
Vector construction and tomato transformation. The vectors for the CRISPR/Cas9 system (pZD_
AtU6_Hpger_Cas9_NPTII and pDeCas9_Kan)44, 45 were kindly provided by Prof. Holger Puchta (Botanical 
Institute II, Karlsruhe Institute of Technology, Karlsruhe, Germany) and Prof. Seiichi Toki [National Agriculture 
and Food Research Organization (NARO), Japan], respectively. The pZD_AtU6_Holger_Cas9_NPTII vector 
was used to introduce the mutation in the C-terminal of SlGAD2 at nucleotide 90 (corresponding to 30 amino 
acids), whereas pDeCas9_Kan was used to develop SlGAD2ΔC48 and SlGAD3ΔC37. The modification of these 
Figure 5. Red-stage fruit GABA content in the T1 generation. GABA content of red-stage fruits (Breaker-stage 
+10 days) was measured by HPLC. All lines were homozygous for TG3C37. Bars indicate standard deviation 
(n = 3) and asterisks indicate statistical differences in relation to control according to the Tukey-Kramer’s test 
(*P < 0.05 and **P < 0.01). ‘C’ is the control plant with WT genotype.
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plasmids was performed following methods presented in previous studies30, 44, 45. Constructed vectors were 
introduced into A. tumefaciens GV226046 via electroporation. Using a highly efficient protocol33, CRISPR/Cas9 
expression was introduced into the tomato genome. Only diploid plants were screened and used in the following 
experiments.
Determination of GAD activity in in vivo assays. SlGAD2ΔC30, SlGAD2ΔC48, and SlGAD3ΔC37 
were cloned into pET-32a vectors (Promega), which were transformed into the E. coli strain BL21(DE3) pLysS. 
Expression was induced by 1 mM isopropyl-β-D(-)-thiogalactopyranoside. The recombinant protein, with a his-
tidine (His) tag, was purified by HisTrap™FF (GE Healthcare, Buckinghamshire, UK). The activity of GAD was 
measured according to previous study22, by directly measuring GABA production after GAD reactions. The pro-
duction of GABA was measured by the GABase method, as described below.
Measuring GABA content by the GABase method. Leaves and Breaker stage +10 days fruits were 
harvested and immediately frozen in liquid nitrogen. Frozen leaves and fruits were ground in liquid nitrogen, 
and free amino acids were extracted from 50 mg of frozen powdered samples with 8% (w/v) trichloroacetic acid. 
Samples were centrifuged at 10,000 × g for 20 min at 4 °C, and the supernatant was transferred to a new tube: 
400 µl of pure diethyl ether were added, and samples were vortexed for 10 min. The mixture was centrifuged at 
10,000 × g for 10 min at 4 °C and, after removing the supernatant, diethyl ether was added and the sample was 
vortexed for another 10 min. A second centrifugation at 10,000 × g for 10 min at 4 °C was performed and, after 
removing the supernatant, the samples were left under a draft for 1 h to completely remove diethylene. The GABA 
content was measured using the GABase method described by Jakoby47, with a slight modification according to 
Akihiro et al.17, or using the HPLC method, as described by Koike et al.14, using completely dried samples dis-
solved in 0.01N HCl.
Statistical analysis. Mean values were compared using the Tukey-Kramer’s test. Data are expressed as 
means ± S.D. The Tukey-Kramer’s test was used to detect significant differences between the control. The level of 
statistical significance was set at*P < 0.05 and **P < 0.01.
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